1. Home
  2. PPSI vs RFL Comparison

PPSI vs RFL Comparison

Compare PPSI & RFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pioneer Power Solutions Inc.

PPSI

Pioneer Power Solutions Inc.

HOLD

Current Price

$4.11

Market Cap

38.6M

Sector

Industrials

ML Signal

HOLD

Logo Rafael Holdings Inc. Class B

RFL

Rafael Holdings Inc. Class B

HOLD

Current Price

$1.51

Market Cap

54.4M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
PPSI
RFL
Founded
2008
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Real Estate
Sector
Industrials
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
38.6M
54.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
PPSI
RFL
Price
$4.11
$1.51
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$12.00
N/A
AVG Volume (30 Days)
73.2K
142.1K
Earning Date
11-13-2025
11-19-2025
Dividend Yield
36.41%
N/A
EPS Growth
N/A
N/A
EPS
2.86
N/A
Revenue
$31,751,000.00
$917,000.00
Revenue This Year
$26.84
N/A
Revenue Next Year
$10.26
N/A
P/E Ratio
$1.44
N/A
Revenue Growth
105.82
43.96
52 Week Low
$2.25
$1.17
52 Week High
$6.19
$3.19

Technical Indicators

Market Signals
Indicator
PPSI
RFL
Relative Strength Index (RSI) 53.33 65.56
Support Level $4.00 $1.45
Resistance Level $4.24 $1.60
Average True Range (ATR) 0.22 0.08
MACD 0.06 0.04
Stochastic Oscillator 72.88 70.05

Price Performance

Historical Comparison
PPSI
RFL

About PPSI Pioneer Power Solutions Inc.

Pioneer Power Solutions Inc designs, manufactures, integrates, services, and sells distributed energy resources, on-site and mobile power generation equipment, and a platform of mobile electric vehicle (EV) charging solutions.. Its principal products and services include custom-engineered electrical transformers, switchgear and engine-generator sets and controls, complemented by a national field-service network to maintain and repair power generation assets.

About RFL Rafael Holdings Inc. Class B

Rafael Holdings Inc is a holding company with interests in clinical and early-stage pharmaceutical companies. Its primary focus is to expand its investment portfolio through opportunistic investments including therapeutics, which address high unmet medical needs. Through the companies it has invested in, the company is focused on; developing Trappsol Cyclo its clinical program, developing instruments to advance minimally invasive surgeries, preclinical cancer metabolism research operations, and developing pharmaceutical-grade technology Unlokt for third-party cannabis manufacturers. It also holds and manages commercial real estate assets in Jerusalem, Israel. The company's reportable segments are; Infusion Technology, which derives maximum revenue, Healthcare, and Real Estate.

Share on Social Networks: